A team of European scientists led by Mario Pezzoti of the University of Verona, Italy, have developed transgenic tobacco plants that can produce biologically-active interleukin-10, an important cytokine. The research, which was part of the Pharma-Planta Project, found that the plants were able to process both viral and mouse forms of IL-10 correctly, producing the active cytokine at high enough levels that it might be possible to use tobacco leaves without lengthy extraction and purification processes. The next step will be to test the plants by feeding them to mice with autoimmune diseases, the authors noted.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze